• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Lawsuit accuses J&J, hospital, doc of unauthorized ceramic-on-metal hip trials

Lawsuit accuses J&J, hospital, doc of unauthorized ceramic-on-metal hip trials

June 19, 2015 By Brad Perriello

depuy orthopaedics logoA purported class action lawsuit accuses a Johnson & Johnson (NYSE:JNJ) subsidiary, a California hospital and an orthopedic surgeon of conducting unauthorized clinical trials without patients’ consent and alleges that the lead plaintiff was implanted with a group of unapproved hip implant components.

The June 17 lawsuit, filed in the U.S. District Court for Northern California, stems from the group of ceramic-on-metal hip components made by J&J subsidiary DePuy Orthopaedics that were implanted in John Muldoon in 2007. After years of alleged pain and discomfort, Muldoon had revision surgery in 2014, replacing the ceramic-on-metal device with a ceramic-on-plastic hip. Muldoon alleges that, although all the components won individual 510(k) clearances, they were never approved for use as a group.

“At the time of plaintiff’s 2007 surgery, the FDA had not approved any ‘ceramic-on-metal’ bearing surface combinations for hip replacement surgeries,” according to the lawsuit [emphasis theirs]. “DePuy did not file a pre-market approval application or start the required 2-year randomized clinical trial for any ceramic-on-metal bearing system until 2009, 2 years after plaintiff had the components surgically implanted.”

The FDA approved the Pinnacle Complete device in June 2011, making it the 1st ceramic-on-metal hip to hit the U.S. market. But 2 years later DePuy shelved the device, citing low sales. Muldoon’s lawsuit alleged that “the true reason DePuy discontinued sales of the Complete acetabular hip system is because the ceramic-on-metal system is defective and unsafe for consumers.”

Muldoon also alleged that DePuy paid kickbacks to Dodgin in exchange for “using a non-FDA approved configuration of DePuy products.”

The lawsuit further claims that DePuy; Muldoon’s original surgeon, Dr. David Dodgin; and the John Muir Medical Center in Walnut Creek, Calif., conspired to run unauthorized clinical trials on “unwitting” patients.

“DePuy and Dr. Dodgin conspired to research and experiment with the use of DePuy components on patients, such as plaintiff, without their knowledge and consent,” the lawsuit alleged. “Through kickbacks and financial inducements, DePuy convinced surgeons to research and experiment with the DePuy components on unwitting patients. In doing so, DePuy and the surgeons they bribed prioritized their own profit over the health and safety of patients.”

The lawsuit seeks class status for patients implanted with ceramic-on-metal hip configurations made by DePuy, compensation for “all economic and non-economic losses” including medical expenses, loss of earnings, disfigurement, pain & suffering, mental anguish and emotional distress, punitive and/or exemplary damages, pre- and post-judgment interest and legal costs.

Filed Under: Clinical Trials, Legal News, Orthopedics Tagged With: depuysynthes, Johnson and Johnson

More recent news

  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy